Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
This explainer defines global market indices, explains their purpose, and outlines how they aggregate data from multiple markets.
27,297 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Oil prices drop to a three-month low following news of a Trump Iran framework, signaling potential relief for inflati...
AI's rapid growth in 2026 is real, but the panic around job loss and market collapse is overblown. This report explai...
The Duquesne Family Office disclosed new and existing stakes in Arm Holdings, Sea Limited, and STMicroelectronics in ...
As quantum computing moves from pilots to real deployments, ionq stock revenue growth becomes a focal point for inves...
The TAN ETF has surged about 82% in the past year, but long-term holders face meaningful fee drag and concentration r...
Wake up to a clear, actionable investing briefing. This Thursday reads roundup distills ten essential market themes i...
Inflation remains a challenge, but certain businesses have pricing power that helps them weather higher costs. This a...
With $1,000, you can build a resilient, diversified starter portfolio. This guide shows how to pick the best stocks w...
As Trump escalates public pressure on the Fed, new chair Warsh faces a test of independence. Markets swing while trad...
Tensions with Iran are driving a puzzling market mix: gold retreats while equities slip only modestly, hinting at a b...
Chip-led gains lift the Nasdaq Composite as chipmakers regain leadership, while software names soften amid mixed dema...